Written by Ken Adrian
Print this

Tuesday, 16 March 2004

image for Finally a Cure for Baldness - Elective Decapitation
Elective Decapitation Takes Weight of Baldness Off of Men's Shoulders

Los Angeles, CA - Scientists at U.C.L.A. have just announced a revolutionary approach to treating baldness - called Elective Decapitation.

The researchers claim that in 100% of cases, baldness is no longer a problem.

Guy O. Tean, a spokesperson for the research program, explains that "the subject voluntarily has the large mass above his (or her) shoulders severed from his (or her) body by means of a sharp cleaving instrument."

The procedure, says Mr. Tean, has been around for some time now but few have really understood the benefits of 'ED'.

"We're just beginning to full appreciate this as a baldness breakthrough..." the researcher suggests "So far, not ONE of our test subjects has complained of baldness after the procedure."

Market analysts, however, have not predicted a bright future for the procedure. Cosmetic surgery futures specialist Beryl Lintch says "This is just too extreme for some people. We believe that 'ED' sales will just be a drop in the bucket compared to other elective cosmetic procedures."

The team at U.C.L.A. disagrees. "We think this will work. We' ve put a lot of effort into this so if it doesn't work, heads will definitely roll."

So far there is a waiting list of over 2,000 men (mostly from France) who are opting for the procedure.

Make Ken Adrian's day - give this story five thumbs-up (there's no need to register, the thumbs are just down there!)

The story above is a satire or parody. It is entirely fictitious.

Do you dream of being a comedy news writer? Click here to be a writer!

More by this writer

View Story
View Story
View Story
View Story
View Story
View Story


Mailing List

Get Spoof News in your email inbox!


What's 4 multiplied by 1?

8 4 6 1
52 readers are online right now!

Go to top

We use cookies to give you the best experience, this includes cookies from third party websites and advertisers.

Continue ? Find out more